Port-Royal Maternity ward - Cochin Hopsital - APHP
Paris, Île-de-France Region, 75014, France
NCT Number: NCT05888324
The purpose of this study is to identify possible links between conditions for carrying out a blood patch (BP) to treat accidental post dural puncture acute headache (PDPH) in the early post partum period and occurrence of chronic headaches at 1 and 6 months.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Paris, Île-de-France Region, 75014, France
It is established that accidental dural puncture promotes the onset of chronic headaches in 25 to 60% of cases but the risk factors for the occurrence of this event are not known.
To identify those risk factors, the investigators will analyze the initial conditions of the accidental breach, the initial manifestations of the PDPH, the methods of carrying out the BP and the patient data.
In this study, the investigators will evaluate (phone questionnaire and score) incidence of chronic headaches at 1 month and 6 months after the realization of a blood patch, incidence of chronic low back pain, impact on daily life, incidence of late recurrences of PDPH, incidence of early and distant complications
In case of failure of effectiveness of the first blood patch, the investigators will search for associated factors: patient data, mode of delivery, initial PDPH, conditions for carrying out the BP.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Questionnaires by phone at 1 and 6 months after inclusion
Time frame: Immediately after BloodPatch procedure
Data collection of diagnosis of the accidental breach :
Time frame: Immediately after BloodPatch procedure
Description of the initial manifestations of post dural puncture acute headache (PDPH) : nature of PDPH
Time frame: Immediately after BloodPatch procedure
Description of the initial manifestations of post dural puncture acute headache (PDPH) : nature of PDPH
Time frame: Immediately after BloodPatch procedure
Description of the initial manifestations of post dural puncture acute headache (PDPH) : nature of PDPH
Time frame: Immediately after BloodPatch procedure
Description of the initial manifestations of post dural puncture acute headache (PDPH) : nature of PDPH
Time frame: Immediately after BloodPatch procedure
Description of the initial manifestations of post dural puncture acute headache (PDPH) : nature of PDPH
Time frame: Immediately after BloodPatch procedure
Description of the methods of carrying out the BloodPatch (BP)
Time frame: Immediately after BloodPatch procedure
Description of the methods of carrying out the BloodPatch (BP)
Time frame: Immediately after BloodPatch procedure
Description of the methods of carrying out the BloodPatch (BP)
Time frame: Immediately after BloodPatch procedure
Description of the methods of carrying out the BloodPatch (BP)
Time frame: Immediately after BloodPatch procedure
Description of the methods of carrying out the BloodPatch (BP)
Time frame: Immediately after BloodPatch procedure
Description of the methods of carrying out the BloodPatch (BP)
Time frame: Immediately after BloodPatch procedure
Patient data collection
Time frame: Immediately after BloodPatch procedure
Patient data collection
Time frame: Immediately after BloodPatch procedure
Patient data collection
Time frame: Immediately after BloodPatch procedure
Patient data collection
Time frame: Immediately after BloodPatch procedure
Patient data collection
Time frame: Immediately after BloodPatch procedure
Patient data collection
Time frame: Immediately after BloodPatch procedure
Patient data collection NSAIDs and analgesics, sphenopalatine ganglion block, ACTH, caffeine, other
Time frame: 1 month after last BloodPatch procedure
Patient data collection
Time frame: 1 month after last BloodPatch procedure
Patient data collection
Time frame: 1 month after last BloodPatch procedure
Patient data collection
Time frame: Immediately after BloodPatch procedure
Patient data collection
Time frame: Immediately after BloodPatch procedure
Patient data collection - Initial efficacy
Time frame: 1 day after BloodPatch procedure
Patient data collection - Initial efficacy
Time frame: At exit of the hospital, up to 2 weeks
Patient data collection - Initial efficacy
Time frame: Month 1
Score - phone questionnaire
Time frame: Month 6
Score - phone questionnaire
Time frame: Month 1
Score - phone questionnaire
Time frame: Month 6
Score - phone questionnaire
Time frame: Month 1
Impact on daily life - Phone questionnaire - Headaches : "Yes/No" Low back pain, "never/rarely/from time to time/often/all the time"
Time frame: Month 6
Impact on daily life - Phone questionnaire - Headaches : "Yes/No" Low back pain, "never/rarely/from time to time/often/all the time"
Time frame: Month 1
Score - phone questionnaire
Time frame: Month 6
Score - phone questionnaire
Time frame: Month 1
Score - phone questionnaire
Time frame: Month 6
Score - phone questionnaire
Time frame: Month 1
Score - phone questionnaire
Time frame: Month 6
Score - phone questionnaire
Time frame: Month 1
Score - phone questionnaire
Time frame: Month 6
Score - phone questionnaire
Time frame: Month 1
In case of failure of efficacy of the 1st BP: patient data, mode of delivery, initial Post dural puncture acute headache (PDPH), conditions for carrying out the BP
Time frame: Month 6
In case of failure of efficacy of the 1st BP: patient data, mode of delivery, initial Post dural puncture acute headache (PDPH), conditions for carrying out the BP
Assistance Publique - Hôpitaux de Paris
Other
Factors Associated With the Onset of Chronic Headaches in Patients Who Received a Blood Patch, Following an Accidental Dural Puncture During Post Partum Period
Acronym: CHROBLOOD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04696627
Brain Diseases, Central Nervous System Diseases
Toronto, Ontario, Canada
View Trial DetailsNCT03080779
Brain Diseases, Central Nervous System Diseases
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT06992063
Brain Diseases, Central Nervous System Diseases
Düzce, Turkey (Türkiye)
View Trial DetailsNCT07494383
Brain Diseases, Central Nervous System Diseases
Mexico City, Mexico
View Trial Details